Related references
Note: Only part of the references are listed.Hyperuricemia Is an Early and Relatively Common Feature in Children with HNF1B Nephropathy but Its Utility as a Predictor of the Disease Is Limited
Marcin Kolbuc et al.
JOURNAL OF CLINICAL MEDICINE (2021)
Genotype and Phenotype Analyses in Pediatric Patients with HNF1B Mutations
Seon Hee Lim et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Hypomagnesaemia is absent in children with autosomal dominant polycystic kidney disease
Tomas Seeman et al.
ANNALS OF CLINICAL BIOCHEMISTRY (2019)
Case report: extreme coronary calcifications and hypomagnesemia in a patient with a 17q12 deletion involving HNF1B
Howard J. Li et al.
BMC NEPHROLOGY (2019)
Phenotypic differences and similarities of monozygotic twins with maturity-onset diabetes of the young type 5
Yasuko Ohara et al.
JOURNAL OF DIABETES INVESTIGATION (2019)
17q12 Deletion Syndrome as a Rare Cause for Diabetes Mellitus Type MODY5
Natascha Roehlen et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2018)
Genetic Testing of Maturity-Onset Diabetes of the Young Current Status and Future Perspectives
Parveena Firdous et al.
FRONTIERS IN ENDOCRINOLOGY (2018)
Long-term reduction in hyperglycemia in advanced type 1 diabetes: the value of induced aerobic glycolysis with BCG vaccinations
Willem M. Kuhtreiber et al.
NPJ VACCINES (2018)
Exocrine pancreatic dysfunction is common in hepatocyte nuclear factor 1β-associated renal disease and can be symptomatic
Rhian L. Clissold et al.
CLINICAL KIDNEY JOURNAL (2018)
Diabetes, Associated Clinical Spectrum, Long-term Prognosis, and Genotype/Phenotype Correlations in 201 Adult Patients With Hepatocyte Nuclear Factor 1B (HNF1B) Molecular Defects. Diabetes Care 2017;40:1436-1443 Response
Daniele Dubois-Laforgue et al.
DIABETES CARE (2018)
HNF1B-associated clinical phenotypes: the kidney and beyond
Detlef Bockenhauer et al.
PEDIATRIC NEPHROLOGY (2016)
Early Developmental Per turbations in a Human Stem Cell Model of MODY5/HNF1B Pancreatic Hypoplasia
Adrian Kee Keong Teo et al.
STEM CELL REPORTS (2016)
Undiagnosed MODY: Time for Action
Jeffrey W. Kleinberger et al.
CURRENT DIABETES REPORTS (2015)
Susceptibility of podocytes to palmitic acid is regulated by fatty acid oxidation and inversely depends on acetyl-CoA carboxylases 1 and 2
Kapil Kampe et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2014)
Early Development of Hyperparathyroidism Due to Loss of PTH Transcriptional Repression in Patients With HNF1β Mutations?
Silvia Ferre et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
MODY History, genetics, pathophysiology, and clinical decision making
Stefan S. Fajans et al.
DIABETES CARE (2011)
Maturity-onset diabetes of the young (MODY): how many cases are we missing?
B. M. Shields et al.
DIABETOLOGIA (2010)
Lack of pancreatic body and tail in HNF1B mutation carriers
I. S. Haldorsen et al.
DIABETIC MEDICINE (2008)
In vitro and pathological investigations of MODY5 with the R276X-HNF1β (TCF2) mutation
Kei Fujimoto et al.
ENDOCRINE JOURNAL (2007)
FXYD proteins: new regulators of Na-k-ATPase
K Geering
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2006)
Lack of TCF2/vHNF1 in mice leads to pancreas agenesis
C Haumaitre et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Islet regeneration during the reversal of autoimmune diabetes in NOD mice
S Kodama et al.
SCIENCE (2003)
The role of the transcriptional regulator Ptf1a in converting intestinal to pancreatic progenitors
Y Kawaguchi et al.
NATURE GENETICS (2002)
Abnormal nephron development associated with a frameshift mutation in the transcription factor hepatocyte nuclear factor-1β
C Bingham et al.
KIDNEY INTERNATIONAL (2000)
Share Paper
